Blog Post

Every day, researchers around the world work with recombinant DNA, infectious agents and other biological materials that carry real risk if handled carelessly. Standing behind…

Adhering to ethical standards in clinical trials is mutually beneficial for both researchers and participants. Throughout a clinical trial, research teams are attempting to gather…

Participant protection is not a one-time event In clinical research, there is often a sense of momentum once a study receives IRB approval. Protocols are…

In Part 1 of this series, we covered the fundamental science behind gene-editing. In Part 2, we focus on execution: clarifying how IRBs and IBCs…

The therapeutic application of gene editing has the potential to reshape what “treatment” can look like for patients with certain genetic and other hard-to-treat diseases….

When conducting clinical research, ensuring participants rights, safety and welfare should be top priority for research teams. One way to safeguard these factors is through…

Author: Garry Coulson, Ph.D. Historically focused on cancer treatments, cell therapies have steadily been advancing into non-oncology indications. The success of chimeric antigen receptor T…

Gene therapy has the promise to revolutionize the treatment of retinal diseases by offering a way to correct the underlying genetic causes of vision loss…

Good clinical practice (GCP) is vital in clinical research, as it shapes how trials are designed, conducted and evaluated. Far from being a simple checklist…

Why IRBs exist, and how they help prevent unethical science from breaking through. The Upside Down of Research In Stranger Things, Hawkins Lab is the…